364 related articles for article (PubMed ID: 31178482)
61. Management of MDA-5 antibody positive clinically amyopathic dermatomyositis associated interstitial lung disease: A systematic review.
McPherson M; Economidou S; Liampas A; Zis P; Parperis K
Semin Arthritis Rheum; 2022 Apr; 53():151959. PubMed ID: 35134633
[TBL] [Abstract][Full Text] [Related]
62. Spontaneous pneumomediastinum in a dermatomyositis patient with anti-melanoma differentiation-associated gene-5 antibody and interstitial lung disease despite an initial response to immunosuppressant.
Chan CWS; Chung HY; Lau CS; Tsang HHL
Int J Rheum Dis; 2019 Mar; 22(3):521-524. PubMed ID: 28580698
[TBL] [Abstract][Full Text] [Related]
63. Predictors of rapidly progressive interstitial lung disease and mortality in patients with autoantibodies against melanoma differentiation-associated protein 5 dermatomyositis.
So J; So H; Wong VT; Ho R; Wu TY; Wong PC; Tam LH; Ho C; Lam TT; Chung YK; Li WL; To CH; Lau CS; Mok CC; Tam LS
Rheumatology (Oxford); 2022 Nov; 61(11):4437-4444. PubMed ID: 35157042
[TBL] [Abstract][Full Text] [Related]
64. Serum Krebs von den Lungen-6 concentrations reflect severity of anti-melanoma differentiation-associated protein 5 antibody positive dermatomyositis associated interstitial lung disease.
Zhu Y; Wang L; Sun Y; Wang J; Lv C; You H; Xu L; Wang F; Zhang M; Tan W; Ke Y
Clin Exp Rheumatol; 2022 Feb; 40(2):292-297. PubMed ID: 34874831
[TBL] [Abstract][Full Text] [Related]
65. Efficacy of plasma exchange in anti-MDA5-positive dermatomyositis with interstitial lung disease under combined immunosuppressive treatment.
Shirakashi M; Nakashima R; Tsuji H; Tanizawa K; Handa T; Hosono Y; Akizuki S; Murakami K; Hashimoto M; Yoshifuji H; Ohmura K; Mimori T
Rheumatology (Oxford); 2020 Nov; 59(11):3284-3292. PubMed ID: 32276271
[TBL] [Abstract][Full Text] [Related]
66. Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review.
Nishi K; Ogura M; Tamai N; Gima M; Ide K; Koinuma G; Kamei K; Ito S
Pediatr Rheumatol Online J; 2022 Aug; 20(1):60. PubMed ID: 35927666
[TBL] [Abstract][Full Text] [Related]
67. Clinical risk factors in patients with interstitial lung disease associated with anti-MDA5 autoantibodies.
Ramos-Martinez E; Rodríguez-Vega EA; Rivera-Matias PA; Falfán-Valencia R; Pérez-Rubio G; Mejia M; González-Pérez MI; Buendia-Roldán I; Mateos-Toledo HN; Serrano JR
Med Clin (Barc); 2023 Dec; 161(12):515-522. PubMed ID: 37567825
[TBL] [Abstract][Full Text] [Related]
68. Coexistence of Anti-Ro52 Antibodies in Anti-MDA5 Antibody-Positive Dermatomyositis Is Highly Associated With Rapidly Progressive Interstitial Lung Disease and Mortality Risk.
Lv C; You H; Xu L; Wang L; Yuan F; Li J; Wu M; Zhou S; Da Z; Qian J; Wei H; Yan W; Zhou L; Wang Y; Yin S; Zhou D; Wu J; Lu Y; Su D; Liu Z; Liu L; Ma L; Xu X; Zang Y; Liu H; Ren T; Wang F; Zhang M; Tan W
J Rheumatol; 2023 Feb; 50(2):219-226. PubMed ID: 35705235
[TBL] [Abstract][Full Text] [Related]
69. Anti-melanoma differentiation-associated gene 5 (anti-MDA5) positive dermatomyositis: early detection is crucial.
Goradia S; Holper S; Lim YZ; Brady SRE
BMJ Case Rep; 2024 Jun; 17(6):. PubMed ID: 38908836
[TBL] [Abstract][Full Text] [Related]
70. The comparison of nailfold videocapillaroscopy findings between anti-melanoma differentiation-associated gene 5 antibody and anti-aminoacyl tRNA synthetase antibody in patients with dermatomyositis complicated by interstitial lung disease.
Wakura R; Matsuda S; Kotani T; Shoda T; Takeuchi T
Sci Rep; 2020 Sep; 10(1):15692. PubMed ID: 32973255
[TBL] [Abstract][Full Text] [Related]
71. [Dermatomyositis associated with anti-MDA5 autoantibody].
Collado MV; Gargiulo MLÁ; Gómez R; Gómez G; Pérez N; Suarez L; Taratuto AL; Aruj P
Medicina (B Aires); 2018; 78(5):360-363. PubMed ID: 30285929
[TBL] [Abstract][Full Text] [Related]
72. [Value of serum YKL-40 in the diagnosis of anti-MDA5-positive patients with dermatomyositis complicated with severe pulmonary injury].
Zhang PL; Yang HX; Zhang LN; Ge YP; Peng QL; Wang GC; Lu X
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 53(6):1055-1060. PubMed ID: 34916681
[TBL] [Abstract][Full Text] [Related]
73. Rapidly progressive interstitial lung disease in patients with anti-melanoma differentiation-associated gene 5-positive dermatomyositis: serial changes on HRCT.
Kim M; Harvey S; Danoff SK; Mecoli CA; Albayda J; Paik JJ; Christopher-Stine L; Illei PB; Lin CT
Emerg Radiol; 2022 Dec; 29(6):961-967. PubMed ID: 35918568
[TBL] [Abstract][Full Text] [Related]
74. A fatal interstitial lung disease in an anti-melanoma differentiation-associated gene 5 (anti-MDA5) antibody negative patient with juvenile dermatomyositis.
Yeşilbaş O; Yıldız M; Yozgat CY; Tahaoğlu I; Yazan H; Çakır E; Adrovic A; Şahin S; Barut K; Kasapçopur Ö
Turk J Pediatr; 2021; 63(5):903-908. PubMed ID: 34738372
[TBL] [Abstract][Full Text] [Related]
75. Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis.
Gono T; Sato S; Kawaguchi Y; Kuwana M; Hanaoka M; Katsumata Y; Takagi K; Baba S; Okamoto Y; Ota Y; Yamanaka H
Rheumatology (Oxford); 2012 Sep; 51(9):1563-70. PubMed ID: 22589330
[TBL] [Abstract][Full Text] [Related]
76. Amyopathic dermatomyositis developing rapidly progressive interstitial lung disease with elevation of anti-CADM-140/MDA5 autoantibodies.
Sato S; Kuwana M; Fujita T; Suzuki Y
Mod Rheumatol; 2012 Aug; 22(4):625-9. PubMed ID: 22124544
[TBL] [Abstract][Full Text] [Related]
77. Autoimmunity against melanoma differentiation-associated gene 5 induces interstitial lung disease mimicking dermatomyositis in mice.
Ichimura Y; Konishi R; Shobo M; Tanaka R; Kubota N; Kayama H; Takeda K; Nomura T; Fujimoto M; Okiyama N
Proc Natl Acad Sci U S A; 2024 Apr; 121(16):e2313070121. PubMed ID: 38588434
[TBL] [Abstract][Full Text] [Related]
78. Elevated serum B-cell activating factor levels in patients with dermatomyositis: Association with interstitial lung disease.
Matsushita T; Kobayashi T; Kano M; Hamaguchi Y; Takehara K
J Dermatol; 2019 Dec; 46(12):1190-1196. PubMed ID: 31631384
[TBL] [Abstract][Full Text] [Related]
79. MDA5-autoimmunity and interstitial pneumonitis contemporaneous with the COVID-19 pandemic (MIP-C).
David P; Sinha S; Iqbal K; De Marco G; Taheri S; McLaren E; Maisuria S; Arumugakani G; Ash Z; Buckley C; Coles L; Hettiarachchi C; Payne E; Savic S; Smithson G; Slade M; Shah R; Marzo-Ortega H; Keen M; Lawson C; Mclorinan J; Nizam S; Reddy H; Sharif O; Sultan S; Tran G; Wood M; Wood S; Ghosh P; McGonagle D
EBioMedicine; 2024 Jun; 104():105136. PubMed ID: 38723554
[TBL] [Abstract][Full Text] [Related]
80. Slowly progressive interstitial lung disease preceding typical dermatomyositis symptoms in anti-melanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis.
Isono T; Nakajima H; Takano K; Kobayashi Y; Kawabata Y; Shimizu Y; Takayanagi N
Respir Med Case Rep; 2021; 34():101491. PubMed ID: 34381685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
